FDA Device Intelligence
HomeBeckman Coulter, Inc. › AU

AU

Beckman Coulter, Inc. · Model OSR61205 · UDI-DI 15099590011925

JMO Prescription
1
510(k) clearances
0
Adverse events
7
Recalls
33
Facilities

Description

UIBC

Recalls

DateFirmReason
2025-06-26Beckman Coulter Inc.Beckman Coulter identified that the Unsaturated Iron Binding Capacity (UIBC) assay is not meeting their labeled hemoglobin interference claims of no significant interference (i.e.,
2024-05-14Ortho-Clinical Diagnostics, Inc.Kit assigned an extended expiration date of 24-Jul-2025 during release. The correct expiration date for Lot 2953 is 24-Jul-2024. If used past its true expiration and the customer
2020-08-18Beckman Coulter Inc.The manufacturer has identified that the use of Unsaturated Iron Binding Capacity (UBIC) lot 2690 will produce erroneously high patient results at the low end of the linear range.
2016-05-24Ortho-Clinical DiagnosticsOrtho Clinical Diagnostics started receiving customer complaints for biased results when using VITROS dTIBC Reagent GEN 30 product. Ortho's investigation confirmed that incorrect c
2012-12-20Siemens Healthcare Diagnostics, Inc.The analytical sensitivity claim of 6 ug/dL (1.1 umol/L) in the Instructions for Use (IFU) is no longer valid. Siemens is conducting a voluntary corrective action for Dimension To
2009-12-16Siemens Healthcare Diagnostics, Inc.Test produces falsely elevated IBCT results and Abnormal Reaction test report messages on heparinized plasma samples.
2008-03-14Diagnostic Chemicals, Ltd.Precipitate in product may cause elevated background absorbance interference.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.